These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2775361)

  • 1. Intracavernous injections of papaverine and phentolamine: correlation with penile brachial index.
    Lakin MM; Montague DK
    Urology; 1989 May; 33(5):383-6. PubMed ID: 2775361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between intracavernous papaverine injection, Doppler analysis and cavernosography in impotent patients.
    Sargin YS; Ozen HA; Başar I; Ergen A; Celebi I; Erol D; Koçal C; Remzi D
    Int Urol Nephrol; 1991; 23(5):489-93. PubMed ID: 1938248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Action of vasoactive drugs in male sexual impotence].
    Morales JC; Elizondo B
    Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic tests for impotence: a comparison of papaverine injection with the penile-brachial index and nocturnal penile tumescence monitoring.
    Abber JC; Lue TF; Orvis BR; McClure RD; Williams RD
    J Urol; 1986 May; 135(5):923-5. PubMed ID: 3959242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction].
    Porst H
    Urologe A; 1988 Jan; 27(1):22-6. PubMed ID: 3284144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is intracavernous injection of papaverine a reliable screening test for vascular impotence?
    Buvat J; Buvat-Herbaut M; Dehaene JL; Lemaire A
    J Urol; 1986 Mar; 135(3):476-8. PubMed ID: 3944889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corpus cavernosum injection treatment of erectile impotence].
    Lenk S; Schönherr G; Korner I
    Z Urol Nephrol; 1990 Oct; 83(10):539-46. PubMed ID: 2095661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B; Donatucci CF; Kaula N; Lue TF
    J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
    Stief CG; Wetterauer U; Kulvelis F; Popken G; Staubesand J; Sommerkamp H
    Urol Int; 1990; 45(6):321-5. PubMed ID: 2288047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can an intracavernous papaverine injection be used to diagnose arteriogenic impotence?
    Imagawa A; Kawanishi Y
    Hinyokika Kiyo; 1988 Jul; 34(7):1185-9. PubMed ID: 3177140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic erection program for the treatment of male impotence.
    Trapp JD
    South Med J; 1987 Apr; 80(4):426-7. PubMed ID: 2436316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence].
    Martin-du Pan R
    Rev Med Suisse Romande; 1989 Apr; 109(4):291-8. PubMed ID: 2660216
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
    Sidi AA; Cameron JS; Duffy LM; Lange PH
    J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.
    Girdley FM; Bruskewitz RC; Feyzi J; Graversen PH; Gasser TC
    J Urol; 1988 Nov; 140(5):972-4. PubMed ID: 3172370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.